$MOBI

Green Park & Golf Ventures II, LLC sold 6,731 shares of MOBI (indirect holdings)

Green Park & Golf Ventures II, LLC sold 6,731 indirectly-held shares of Mobia Medical, Inc. (MOBI) on 2026-05-11.

Original reporting
SEC EDGAR · Green Park & Golf Ventures II, LLC
Published Jun 29, 2026, 11:56 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 30, 2026, 12:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$MOBI
Neutral
medium confidence
Mentioned
$MOBI
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MOBINeutralLow
01

Why it matters

A 10% owner sold 6,731 shares on 2026-05-11; the filing does not disclose sale price/value and does not cite a 10b5-1 plan, reducing interpretability for traders.

02

Market read

Traders may monitor for follow-on insider activity, but this single sale without value disclosure is unlikely to drive a major repricing.

03

What to watch

No total value or execution price is provided, and the absence of a 10b5-1 plan does not, by itself, confirm bearish intent without additional context (e.g., prior trades, pattern, or follow-on buys).

Relevance 4/10Novelty 4/10Timing: after-hours/filing update on 2026-06-29 (Form 4)

Background

The article is an SEC Form 4 insider transaction disclosure for Mobia Medical, Inc. (MOBI).

Company-level read

Ticker impact

$MOBINeutralMedium confidence
Context

Green Park & Golf Ventures II, LLC (10% owner) sold 6,731 shares of Mobia Medical via an open-market Form 4 filed June 29.

Expected impact

Low likelihood of a sustained price move; any reaction would likely be short-lived and sentiment-driven.

Evidence & confidence

The filing discloses direction (sale) and share count, but provides no price/total value and no 10b5-1 plan, limiting inference about materiality.

Market effects

Minimal; this is company-specific insider transaction data with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

The sale may be non-informational (liquidity/tax/portfolio rebalancing), especially since the filing lacks disclosed price/value and any stated reason.

Key entities

  • Mobia Medical, Inc.

    Subject of the Form 4 insider transaction; ticker MOBI.

  • Green Park & Golf Ventures II, LLC

    10% owner who executed an open-market sale of 6,731 shares (indirect holdings).

Related articles

$MOBIMedAI 8/10

Mobia Medical Announces Publication of Two-Year Data from VNS-REHAB Trial Demonstrating Durable and Continued Stroke Recovery with Vivistim® Paired VNS™ Therapy

Mobia Medical (Nasdaq: MOBI) said Neurology published two-year follow-up results from its VNS-REHAB trial of Vivistim Paired VNS Therapy in chronic ischemic stroke. Among 49 participants, 76% met response on FMA-UE and/or WMFT, with average gains of +7.5 FMA-UE and +0.63 WMFT. Mobia reported improvements in daily living and quality of life sustained for at least two years.

$MOBIMedAI 8/10

Mobia Medical poised for commercial expansion, BofA says in initial coverage

Bank of America initiated coverage of Mobia Medical (NASDAQ:MOBI) with a Buy rating and a $16 price target, citing growth potential for its Vivistim stroke-recovery therapy. The firm estimates a US addressable market above $30B, with about 200,000 new qualifying patients annually. It expects salesforce expansion and notes favorable reimbursement (avg ~$53,000 facility reimbursement vs ~$36,000 ASP). Key risks include adoption and reimbursement changes.